Back

Ablation should be 1st line therapy in the high risk Brugada Syndrome patient - Rebuttal PRO

20 March 2018 (09:00 - 09:05)
Organised by:
Congress Presentation Part of: Controversies in channelopathy Brugada Syndrome EHRA Premium Access EHRA 2018

11 More presentations in this session

Presentation thumbnail
Opening question
Slides Video
Presentation thumbnail
Ablation should be 1st line therapy in the high risk Brugada Syndrome patient - PRO
Professor V. Probst (Nantes, FR)
Slides Video
Presentation thumbnail
Ablation should be 1st line therapy in the high risk Brugada Syndrome patient - CON
Professor S. Viskin (Tel Aviv, IL)
Slides Video
Presentation thumbnail
Ablation should be 1st line therapy in the high risk Brugada Syndrome patient - Rebuttal CON
Video
Presentation thumbnail
Chairperson conclusion & Closing question
Slides Video

Access the full session

Session thumbnail
Controversies in channelopathy

The Event

Event poster

EHRA 2018

20 March 2018 09:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources